BindingDB logo
myBDB logout

4 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
11170651 47 AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series.EBI Metabasis Therapeutics Inc.
10780908 40 AMP deaminase inhibitors. 4. Further N3-substituted coformycin aglycon analogues: N3-alkylmalonates as ribose 5'-monophosphate mimetics.EBI Metabasis Therapeutics Inc.
25459661 19 Inhibition of AMP deaminase activity does not improve glucose control in rodent models of insulin resistance or diabetes.BDB AstraZeneca R&D